CuraGen to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology ...( BRANFORD Conn. June 6 /- CuraGen ...),Health
Navigation Links
CuraGen to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
Date:6/6/2008
BRANFORD, Conn., June 6 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN) announced today that Dr. Timothy Shannon, President and Chief Executive Officer, will present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference on Wednesday, June 11, 2008, at 3:30 p.m. Eastern time. The conference is being held at the New York Palace Hotel in New York, NY.
Access to a live webcast of the presentation will be available from the Investor Relations section of CuraGen's website at http://www.curagen.com. A replay of the webcast will be available after the presentation and archived for 30 days thereafter.
About CuraGen
CuraGen Corporation (Nasdaq: CRGN) is a clinical-stage
biopharmaceutical company developing promising approaches for the treatment
of cancer. CuraGen Corporation is headquartered in Branford, Connecticut.
For additional information please visit http://www.curagen.com.
CuraGen Contact:
Glenn Schulman, Pharm.D.
Director Medical Communications
(888) 436-6642
CRGN-G
'/>"/>
| SOURCE CuraGen Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. CuraGen Corporation Regains NASDAQ Listing Compliance
2. CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million
3. CuraGen Reports First Quarter 2008 Financial Results
4. CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
5. CuraGen Reports Third Quarter 2007 Financial Results
6. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
7. Alexion to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
8. The febit science lounge presents: Webinar About Role of Non-Protein-Coding RNA in Human Genome Set for 11 a.m. EDT on June 12
9. NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
10. MAP Pharmaceuticals to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
11. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
Post Your Comments:
(Date:10/7/2008)... Licensed Chiropractor Dr. Richard A. Huntoon... Newburgh, NY (Vocus) October 7, 2008 -- I...the most stressful times in its history. High gas...s of everything from phone bills to electric to fo... stress. And with growing stress levels come vari...
(Date:10/7/2008)... Mickie Bellah,s Luminescence Series painting...tional Fine Art Gallery in the Chelsea District of... TX (PRWEB) October 7, 2008 -- Austin Artist Micki... her Luminescence Series paintings at Amsterdam Wh...a District of New York City,October 10, 2008. Bell...
(Date:10/6/2008)...not helping fight against childhood obesity, resea...Day News) -- Three-quarters of middle schools have...are sold, a new study finds. , The research dem...middle schools, and "that those vending machines d...dy author Amy Virus, a registered dietitian with t...
(Date:10/6/2008)...6 /PRNewswire-FirstCall/ -- Volcano Corporation,(N...acturing and sales of,products for the diagnosis a...ease, today announced the relocation of its corpor... Cordova to San Diego. The new corporate,headquart...ego and now,houses corporate executives, marketing...
Breaking Medicine News(10 mins):Health News:Prescriptions for Stress 2Health News:Prescriptions for Stress 3Health News:Vending Machines Found in Most Middle Schools 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 3Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 4...m, the UNAIDS and UNICEF Special Representative fo...f education, in bettering the lot of the children ...he anti-Aids movement a morale boost. The Princes...ast African Country said 'During the past days, I ...
...new research is to be believed hunger can help wit...revelation comes from American scientists who foun...ry retention. The mechanism is by way of an increa... area of the brain where new memories are formed. ...
...s prompted a bird flu panic across the whole count...ere is no reason for panic even after thousands of... Across the country, state governments began taki... deadly H5N1 strain of the avian flu that is known...
...government is considering the ban on import of egg...tion. // Orissa is currently dependent upon Andhra...gs. A meeting between the Animal Husbandry and Ve...was held recently to alleviate any fears among the...
Other Medicine News:Health News:Indian Government: No Reason For Worry About Bird Flu 2Health News:Indian Government: No Reason For Worry About Bird Flu 3(Date:10/7/2008)... DIEGO, Oct. 7 /- Ardea Bio...at a poster entitled "RDEA119, a Potent,and Highly...an Sulfate,Sodium (DSS) -- induced Chronic Colitis...f Gastroenterology (ACG) 2008 Annual Meeting in Or...om a preclinical study of,RDEA119, the Company,s l...
(Date:10/6/2008)...NCETON, N.J., Oct. 6 /- Pha...ard E.T. Smith, Ph.D., is joining the,Company as V...Communications. Dr. Smith will be responsible for ...irectly to Chief Financial Officer Kurt,Leutzinger...and Senior Biotechnology,Analyst at JPMorgan Secur...
(Date:10/6/2008)...-winning video clips feature children, parents dis...udies, BETHESDA, Md., Oct. 6 /PRNewswire-USNewswi...es, research in children saves lives and improves ...he National Institutes of,Health (NIH), "Children ...icalStudies.nhlbi.nih.gov ), offers parents and he...
(Date:10/6/2008)...MOUTH MEETING, Pa., Oct. 6 /PRNewswire-FirstCall/ ...rted data from its second Phase 1,clinical trial o...ndidate,for the treatment of type 2 diabetes and o...validated molecular target that controls the funct...malize glucose and decrease,appetite. In the study...
Breaking Medicine Technology:Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 2Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 3Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting 4Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 2Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 2Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 3Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children 4Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4Cigarette smoke alcohol damage hearts worse as combo 1307 1Cigarette smoke alcohol damage hearts worse as combo 1307 2The Advisory Board Company to Present at CIBC World Markets Mid 26 Small Cap Best Ideas Conference 6794 1UNT Health Science Center Appoints Eight New Faculty Members 6792 1UNT Health Science Center Appoints Eight New Faculty Members 6792 2UNT Health Science Center Appoints Eight New Faculty Members 6792 3Help Save Lives This Holiday Season by Donating Blood 6790 1Help Save Lives This Holiday Season by Donating Blood 6790 2[1] Ardea Biosciences Presents Preclinical Anti-Inflammatory Data on its Lead MEK Inhibitor, RDEA119, at the ACG 2008 Annual Meeting[0] Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications[0] Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children[0] Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
... Food and Drug,Administration (FDA) announced the ...against PharmaFab Inc., its subsidiary, PFab,LP, a...s president,and Russ McMahen, PFab,s vice preside...facture and distribution of prescription and,over-...l because,they are not produced according to the r...
...ewswire-FirstCall/ --,Allos Therapeutics, Inc. tod...ommunities, with a favorable opinion of the Commit...Medicines Agency (EMEA),has granted orphan drug d...pralatrexate) for the treatment of patients with,p...e U.S. Food and,Drug Administration (FDA) awarded ...
Other Medicine Technology:Major Manufacturer of Unapproved and Adulterated Drugs 2Major Manufacturer of Unapproved and Adulterated Drugs 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4New Image Drainable Pouch, Ultra-Clear without Filter
New Image Drainable Mini-Pouch, Beige
New Image Cut-to-Fit Flextend Skin Barrier, Floating Flange, with Tape
New Image Cut-to-Fit Convex Flextend Skin Barrier, with Tape
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |